Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux
Marcello Di Nisio,1,2 Ettore Porreca3 1Department of Medical, Oral and Biotechnological Sciences, University G D'Annunzio of Chieti-Pescara, Chieti, Italy; 2Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; 3Department of Medicine and Aging, Centre for Agi...
Main Authors: | Di Nisio M, Porreca E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-09-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/prevention-of-venous-thromboembolism-in-hospitalized-acutely-ill-medic-a14352 |
Similar Items
-
Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01) -
Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery
by: David Bergqvist
Published: (2006-12-01) -
An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients
by: Kleber Franz-Xaver, et al.
Published: (2006-07-01) -
Study on the safety and effectiveness of low-dose vs. regular-dose fondaparinux in preventing venous thromboembolism prophylaxis following total knee arthroplasty
by: Ping-bo Chen, et al.
Published: (2023-07-01) -
Venous Thromboembolism Prophylaxis and The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) Score in Medical Illness Patients
by: Dania Artriana Riswandi, et al.
Published: (2020-04-01)